Previous investigations, including MR studies, have demonstrated that T2D and FI are associated with a higher MASLD risk, as well as increased levels of hepatic fat and ALT [4, 13–15, 42, 43], suggesting that the associations are likely causal. The gene discussed is GPT; the disease is type 2 diabetes mellitus.